Analysis of High-Dose Ascorbate-Induced Cytotoxicity in Human Glioblastoma Cells and the Role of Dehydroascorbic Acid and Iron
Authors:
- Alban PiotrowskyAPAlban Piotrowsky
- Markus BurkardMarkus Burkard
- Katharina HammerschmidtKHKatharina Hammerschmidt
- Hannah K. RupleHRHannah K. Ruple
- Pia NonnenmacherPNPia Nonnenmacher
- Monika SchumacherMSMonika Schumacher
- Christian LeischnerCLChristian Leischner
- Susanne BerchtoldSBSusanne Berchtold
- Luigi MarongiuLuigi Marongiu
- Thomas A. KuferTKThomas A. Kufer
- Ulrich M. LauerULUlrich M. Lauer
- Olga RennerOROlga Renner
Open Access
- 10 September 2024
- journal article
- research article
- Published by MDPI AG in Antioxidants
- Vol. 13 (9) , 1095
Abstract
Several studies have demonstrated, both in vitro and in animal models, the anti-tumor efficacy of high-dose ascorbate treatment against a variety of tumor entities, including glioblastoma, the most common and aggressive primary malignant brain tumor. The aim of this study was to investigate the effects of high-dose ascorbate as well as dehydroascorbic acid on human glioblastoma cell lines and to evaluate different treatment conditions for the combined administration of ascorbate with magnesium (Mg2+) and iron (Fe3+). Intracellular levels of reactive oxygen species and the induction of cell death following ascorbate treatment were also investigated. We demonstrated high cytotoxicity and antiproliferative efficacy of high-dose ascorbate in human glioblastoma cells, whereas much weaker effects were observed for dehydroascorbic acid. Ascorbate-induced cell death was independent of apoptosis. Both the reduction in cell viability and the ascorbate-induced generation of intracellular reactive oxygen species could be significantly increased by incubating the cells with Fe3+ before ascorbate treatment. This work demonstrates, for the first time, an increase in ascorbate-induced intracellular ROS formation and cytotoxicity in human glioblastoma cells by pre-treatment of the tumor cells with ferric iron, as well as caspase-3 independence of cell death induced by high-dose ascorbate. Instead, the cell death mechanism caused by high-dose ascorbate in glioblastoma cells shows evidence of ferroptosis. The results of the present work provide insights into the efficacy and mode of action of pharmacological ascorbate for the therapy of glioblastoma, as well as indications for possible approaches to increase the effectiveness of ascorbate treatment.Keywords
Funding Information
- Dr. Hans Fritz Stiftung (3140080501, D.31.15100, D.32.22506, AZ 16 (34) 8402.43/0454 E, D3021947)
- PASCOE pharmazeutische Praeparate GmbH (3140080501, D.31.15100, D.32.22506, AZ 16 (34) 8402.43/0454 E, D3021947)
- Ministry of Rural Affairs and Consumer Protection Baden-Wuerttemberg (3140080501, D.31.15100, D.32.22506, AZ 16 (34) 8402.43/0454 E, D3021947)
- Else-Uebelmesser-Stiftung (3140080501, D.31.15100, D.32.22506, AZ 16 (34) 8402.43/0454 E, D3021947)
This publication has 64 references indexed in Scilit:
- Exogenous iron impairs the anti-cancer effect of ascorbic acid both in vitro and in vivoJournal of Advanced Research, 2022
- Vitamin C induces ferroptosis in anaplastic thyroid cancer cells by ferritinophagy activationBiochemical and Biophysical Research Communications, 2021
- Transferrin Receptor Is a Specific Ferroptosis MarkerCell Reports, 2020
- High doses of sodium ascorbate interfere with the expansion of glioblastoma multiforme cells in vitro and in vivoLife Sciences, 2019
- The Interrelationship of Pharmacologic Ascorbate Induced Cell Death and FerroptosisPathology and Oncology Research, 2018
- Data Triumph at CCancer Cell, 2017
- O2⋅− and H2O2-Mediated Disruption of Fe Metabolism Causes the Differential Susceptibility of NSCLC and GBM Cancer Cells to Pharmacological AscorbateCancer Cell, 2017
- An assay for the rate of removal of extracellular hydrogen peroxide by cellsRedox Biology, 2013
- Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell DeathCell, 2012
- Copper in diseases and treatments, and copper‐based anticancer strategiesMedicinal Research Reviews, 2009